Rhythm

HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

Southlake, TX, May 20, 2025 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq:HSCS) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Chief Executive Officer Andrew Simpson will deliver a live presentation and participate in a Q&A session at the Emerging Growth Conference 82.

Envello Core Named “Best IoT Healthcare Wearable Device” in 2025 MedTech Breakthrough Awards Program

Envello Medical Receives Prestigious International Award Recognizing Standout Digital Health & Medical Technology Products and Companies RICHMOND, Va.–(BUSINESS WIRE)–Envello Medical, a subsidiary company of NIRSense, today announced that it has been selected as winner of the “Best IoT Healthcare Wearable Device” award in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, […]